SCHEMBL17058210

SCHEMBL17058210

Cc1cc(CNSN2CCN(c3cnn(-c4cc(F)cc(F)c4)c(=O)c3OCC3(C)CC3)CC2)ccc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17058510 0.92 SLC2A1 (0.32) —
SCHEMBL17058467 0.91 NPSR1 (0.33) —
SCHEMBL17058576 0.90 ABL1 (0.34) —
SCHEMBL17058543 0.89 — —
SCHEMBL17058575 0.89 SLC2A1 (0.30) —
SCHEMBL17058025 0.89 SLC2A1 (0.31) —
SCHEMBL17058205 0.89 SLC2A1 (0.34) —
SCHEMBL17058432 0.88 MCHR1 (0.38) —
SCHEMBL17058248 0.88 SLC2A1 (0.31) —
SCHEMBL11945956 0.86 POLB (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback